Nom du produit:3-Chloro-1-(2,3-dihydro-1H-inden-5-yl)propan-1-one

IUPAC Name:3-chloro-1-(2,3-dihydro-1H-inden-5-yl)propan-1-one

CAS:39105-39-0
Formule moléculaire:C12H13ClO
Pureté:95%
Numéro de catalogue:CM269839
Poids moléculaire:208.69

Unité d'emballage Stock disponible Prix($) Quantité
CM269839-50mg in stock ŮƚŌ
CM269839-100mg in stock ŮŮǸ
CM269839-250mg in stock ŮǙǸ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:39105-39-0
Formule moléculaire:C12H13ClO
Point de fusion:-
Code SMILES:O=C(C1=CC2=C(CCC2)C=C1)CCCl
Densité:
Numéro de catalogue:CM269839
Poids moléculaire:208.69
Point d'ébullition:
N° Mdl:MFCD00029138
Stockage:

Category Infos

Indenes
Indenes are useful building blocks found in a variety of biologically relevant products.

Column Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.
NT-0796
NodThera’s NLRP3 inhibitor NT-0796 reverses neuroinflammation in Parkinson’s Disease phase Ib/IIa trial. The positive data from its Phase Ib/IIa study indicates that NT-0796 reduces key neuroinflammatory and inflammatory biomarkers in Parkinson’s disease patients to the levels found in healthy elderly controls over 28 days.
The NLRP3 inflammasome is a main mediator of inflammation in many pathologies. NT-0796 selectively inhibits NLRP3, lowering levels of both pro-inflammatory cytokines IL-1β and IL-18. This action delivers therapeutic effects directly to immune cell types responsible for inflammatory diseases, including peripheral and neuroinflammatory diseases.

Related Products